DMARDS incorporated injectable hydrogels in cartilage tissue regeneration: a review

References

• Cheng, G.; Davoudi, Z.; Xing, X.; Yu, X.; Cheng, X.; Li, Z.; Deng, H.; Wang, Q. Advanced Silk Fibroin Biomaterials for Cartilage Regeneration. ACS Biomater. Sci. Eng. Aug 13, 2018, 4(8), 2704–2715. DOI: 10.1021/acsbiomaterials.8b00150.
   PubMed Web of Science ®Google Scholar
• Binch, A. L. A.; Fitzgerald, J. C.; Growney, E. A.; Barry, F. Cell-Based Strategies for IVD Repair: Clinical Progress and Translational Obstacles. Nat. Rev. Rheumatol. Mar 1, 2021, 17(3), 158–175. DOI: 10.1038/s41584-020-00568-w.
   PubMed Web of Science ®Google Scholar
• Vinatier, C.; Guicheux, J. Cartilage Tissue Engineering: From Biomaterials and Stem Cells to Osteoarthritis Treatments. Annals Of Phy. And Rehabilitation Medicine Jun 1, 2016, 59(3), 139–144. DOI: 10.1016/j.rehab.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Brown, T. P.; M Handorf, A.; Bae, J. W.; Li, W. J. Stem Cell-Based Tissue Engineering Approaches for Musculoskeletal Regeneration. Curr. Pharm. Des. 2013, 19(19), 3429–3445. DOI: 10.2174/13816128113199990350.
   PubMed Web of Science ®Google Scholar
• Goldring, M. B.; Otero, M.; Plumb, D. A.; Dragomir, C.; Favero, M.; Ei Hachem, K.; Hashimoto, K.; Roach, H. I.; Olivotto, E.; Borzì, R. M., et al. Roles of Inflammatory and Anabolic Cytokines in Cartilage Metabolism: Signals and Multiple Effectors Converge Upon Mmp-13 Regulation in Osteoarthritis. Eur. Cells Mater. 2011, 21, 202–220. DOI: 10.22203/eCM.v021a16.
   PubMed Web of Science ®Google Scholar
• Vinatier, C. B. C.-M. C. G. J. B. J.-M. J. C. W. P. G. J. N. D.; Bouffi, C.; Merceron, C.; Gordeladze, J.; Brondello, J.-M.; Jorgensen, C.; Weiss, P.; Guicheux, J.; Noel, D. Cartilage Tissue Engineering: Towards a Biomaterial-Assisted Mesenchymal Stem Cell Therapy. Current Stem Cell Res. Therapy 2009, 4(4), 318–329. DOI: 10.2174/157488809789649205.
   PubMed Web of Science ®Google Scholar
• Ng, J.; Bernhard, J.; Vunjak-Novakovic, G. Mesenchymal Stem Cells for Osteochondral Tissue Engineering. Methods Mol. Biol. 2016, 35–54. DOI: 10.1007/978-1-4939-3584-0_3.
   PubMedGoogle Scholar
• Bao, W.; Li, M.; Yang, Y.; Wan, Y.; Wang, X.; Bi, N.; Li, C. Advancements and Frontiers in the High Performance of Natural Hydrogels for Cartilage Tissue Engineering. Front. Chem. 8. DOI: 10.3389/fchem.2020.00053. (Feb. 12, 2020).
   Web of Science ®Google Scholar
• Caplan, A. I. Mesenchymal Stem Cells: Time to Change the Name! Stem Cells Transl. Med. Jun., 2017, 6(6), 1445–1451. DOI: 10.1002/sctm.17-0051.
   PubMed Web of Science ®Google Scholar
• Višňa, P.; Paša, L.; Čižmář, I.; Hart, R.; Hoch, J. Treatment of Deep Cartilage Defects of the Knee Using Autologous Chondrograft Transplantation and by Abrasive Techniques - a Randomized Controlled Study. Acta. Chir. Belg. 2004, 104(6), 709–714. DOI: 10.1080/00015458.2004.11679648.
   PubMed Web of Science ®Google Scholar
• Oldershaw, R. A. Cell Sources for the Regeneration of Articular Cartilage: The Past, the Horizon and the Future. Int. J. Experimental Pathology Dec., 2012, 93(6), 389–400. DOI: 10.1111/j.1365-2613.2012.00837.x.
   PubMed Web of Science ®Google Scholar
• Vinatier, C., Merceron, C., and Guicheux, J. Osteoarthritis: From Pathogenic Mechanisms and Recent Clinical Developments to Novel Prospective Therapeutic Options. Drug. Discovery. Today Dec 1, 2016. 21(12), 1932–1937. DOI: 10.1016/j.drudis.2016.08.011.
   PubMed Web of Science ®Google Scholar
• Schmidt, M. B.; Chen, E. H.; Lynch, S. E. A Review of the Effects of Insulin-Like Growth Factor and Platelet Derived Growth Factor on in vivo Cartilage Healing and Repair. Osteoarthritis. And Cartilage May., 2006, 14(5), 403–412. DOI: 10.1016/j.joca.2005.10.011.
   PubMed Web of Science ®Google Scholar
• Hunziker, E. B. Articular Cartilage Repair: Basic Science and Clinical Progress. A Review of the Current Status and Prospects. Osteoarthritis. And Cartilage. 2002, 10(6), 432–463. DOI: 10.1053/joca.2002.0801.
   PubMed Web of Science ®Google Scholar
• Malda, J.; Murali, A.; Parameswaran, R. 25th Anniversary Article: Engineering Hydrogels for Biofabrication. Adv. Mate. 2013, 25(36), 5011–5028. DOI: 10.1002/adma.201302042.
   PubMed Web of Science ®Google Scholar
• Bian, L.; Fong, J. V.; Lima, E. G.; Stoker, A. M.; Ateshian, G. A.; Cook, J. L.; Hung, C. T. Dynamic Mechanical Loading Enhances Functional Properties of Tissue-Engineered Cartilage Using Mature Canine Chondrocytes. Tissue. Engin. Part A 2010, 16(5), 1781–1790. DOI: 10.1089/ten.tea.2009.0482.
   PubMed Web of Science ®Google Scholar
• Kon, E., Filardo, G., Tschon, M., Fini, M., Giavaresi, G., Reggiani, L. M., Chiari, C., Nehrer, S., Martin, I., Salter, D. M., Ambrosio, L.; et al. Tissue Engineering for Total Meniscal Substitution: Animal Study in Sheep Model—Results at 12 Months. Tissue Engineering. - Part A Aug 1, 2012. 18(15–16) pp. 1573–1582. DOI: 10.1089/ten.tea.2011.0572.
   PubMed Web of Science ®Google Scholar
• Gremese, E.; Alivernini, S.; Tolusso, B.; Zeidler, M. P.; Ferraccioli, G. JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. J. Leukocyte Biol. Nov 1, 2019. 106(5), 1063–1068. DOI: 10.1002/JLB.5RU0519-145R.
   PubMed Web of Science ®Google Scholar
• Zhu, S.; Li, Y.; He, Z.; Ji, L.; Zhang, W.; Tong, Y.; Luo, J.; Yu, D.; Zhang, Q.; Bi, Q. Advanced injectable hydrogels for cartilage tissue engineering. Front. Bioeng. Biotechnol. Sep 8, 2022, 10. DOI: 10.3389/fbioe.2022.954501.
   Web of Science ®Google Scholar
• Caporali, R.; Caprioli, M.; Bobbio-Pallavicini, F.; Montecucco, C. DMARDS and infections in rheumatoid arthritis. Autoimmunity. Rev. Dec., 2008, 8(2), 139–143. DOI: 10.1016/j.autrev.2008.05.001.
   PubMed Web of Science ®Google Scholar
• Väänänen, T.; Vuolteenaho, K.; Kautiainen, H.; Nieminen, R.; Möttönen, T.; Hannonen, P.; Korpela, M.; Kauppi, M. J.; Laiho, K.; Kaipiainen-Seppänen, O., et al. Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PLoS. One Aug., 2017, 12(8), e0183294. DOI: 10.1371/journal.pone.0183294.
   PubMed Web of Science ®Google Scholar
• Genovese, M. C.; Genovese, M. C.; Fleischmann, R.; Kivitz, A.; Lee, E. B.; Van Hoogstraten, H.; Kimura, T.; Burmester, G. R. Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies. Arthritis. Res. Ther. 2020, 22(1). DOI: 10.1186/s13075-020-02194-z.
   Web of Science ®Google Scholar
• Ramiro, S.; Sepriano, A.; Chatzidionysiou, K.; Nam, J. L.; Smolen, J. S.; van der Heijde, D.; Dougados, M.; van Vollenhoven, R.; Bijlsma, J. W.; Burmester, G. R., et al. Safety of synthetic and biological DMARDs: A systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum. Dis. Jun., 2017, 76(6), 1101–1136. DOI: 10.1136/annrheumdis-2016-210708.
   PubMed Web of Science ®Google Scholar
• Boleto, G.; Kanagaratnam, L.; Dramé, M.; Salmon, J. H. Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: A systematic review and meta-analysis. Seminars in Arthritis. and Rheumatism Aug 1, 2019. 49(1), 35–42. DOI: 10.1016/j.semarthrit.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Gaujoux-Viala, C., et al. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann. Rheum. Dis. Jun., 2010, 69(6), 1004–1009. DOI: 10.1136/ard.2009.127225.
   PubMed Web of Science ®Google Scholar
• Smolen, J. S.; Landewé, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gorter, S.; Knevel, R.; Nam, J.; Schoels, M., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. Jun., 2010, 69(6), 964–975. DOI: 10.1136/ard.2009.126532.
   PubMed Web of Science ®Google Scholar
• Vinson, D.; Molet-Benhamou, L.; Degboé, Y.; den Broeder, A.; Ibrahim, F.; Pontes, C.; Westhovens, R.; Závada, J.; Pham, T.; Barnetche, T., et al. Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: A systematic analysis of the literature and meta-analysis. Arthritis Res. Ther. Apr., 2020, 22(1). DOI: 10.1186/s13075-020-02188-x.
   PubMed Web of Science ®Google Scholar
• Kolasinski, S. L.; Neogi, T.; Hochberg, M. C.; Oatis, C.; Guyatt, G.; Block, J.; Callahan, L.; Copenhaver, C.; Dodge, C.; Felson, D., et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis. Rheumatol. Feb., 2020, 72(2), 220–233. DOI: 10.1002/art.41142.
   PubMed Web of Science ®Google Scholar
• Smolen, J. S.; Landewé, R.; Breedveld, F. C.; Buch, M.; Burmester, G.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gossec, L.; Nam, J., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. Mar., 2014, 73(3), 492–509. DOI: 10.1136/annrheumdis-2013-204573.
   PubMed Web of Science ®Google Scholar
• Rubbert-Roth, A.; Tak, P. P.; Zerbini, C.; Tremblay, J.-L.; Carreno, L.; Armstrong, G.; Collinson, N.; Shaw, T. M. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: Results of a Phase III randomized study (MIRROR). Rheumatology. May., 2010, 49(9), 1683–1693. DOI: 10.1093/rheumatology/keq116.
   PubMed Web of Science ®Google Scholar
• Hoffmeister, R. T.; Spokane, W. Methotrexate Therapy in Rheumatoid Arthritis: 15 Years Experience. Am. j. med. 1983, 75(6), 69–73. DOI: 10.1016/0002-9343(83)90477-1.
   PubMedGoogle Scholar
• Weiner, G. J. Rituximab: Mechanism of action. Semin. Hematol. Apr., 2010, 47(2), 115–123. DOI: 10.1053/j.seminhematol.2010.01.011.
   PubMed Web of Science ®Google Scholar
• Walsh, D. A.; McWilliams, D. F. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat. Review Rheumatology Jan 1, 2014 10(10), 581–592. DOI: 10.1038/nrrheum.2014.64. ().
   PubMed Web of Science ®Google Scholar
• Wang, L.; Huang, S.; Li, S.; Li, M.; Shi, J.; Bai, W.; Wang, Q.; Zheng, L.; Liu, Y. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study,” Drug. Des. Devel. Ther. vol. 13, pp. 4331–4340, 2019, doi: 10.2147/DDDT.S225613.
   PubMed Web of Science ®Google Scholar
• De Bari, C. Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis. Research. and Therapy May 1, 2015. 17(1). DOI: 10.1186/s13075-015-0634-1.
   Google Scholar
• Onrust, S. V.; Lamb, H. M.; Barman Balfour, J. A. Rituximab. Drugs 1999, 58(1), 79–88. DOI: 10.2165/00003495-199958010-00009.
   PubMed Web of Science ®Google Scholar
• Üppers, A. K.; Lein, L. K.; Artin, M. -Eo, L.; Ansmann, H.; Laus, K.; Ajewsky, R. Mechanisms of disease cellular o rigin of h uman b-c ell l ymphomas the human peripheral b-cell repertoire and its generation Antibody Specificity and Selection of B Cells. Cancers 2013, 12(6), 1–14.
   Google Scholar
• Parker, D. C. T cell-dependent b cell activation. 1993. [Online]. Available: www.annualreviews.org.
   Google Scholar
• “ nejm198311033091805.
   Google Scholar
• Kremer, J. M. Toward a Better Understanding of Methotrexate. Arthritis Rheum. May., 2004, 50(5), 1370–1382. DOI: 10.1002/art.20278.
   PubMed Web of Science ®Google Scholar
• Szekanecz, Z.; Besenyei, T.; Szentpétery, Á.; Koch, A. E. Angiogenesis and vasculogenesis in rheumatoid arthritis. Current. Opinion in Rheumatology May., 2010, 22(3), 299–306. DOI: 10.1097/BOR.0b013e328337c95a.
   PubMed Web of Science ®Google Scholar
• Folkman, J. Angiogenesis. Annu. Rev. Med. 2006, 57(1), 1–18. DOI: 10.1146/annurev.med.57.121304.131306.
   PubMedGoogle Scholar
• Lee, K. Y.; Mooney, D. J. Hydrogels for tissue engineering. Chem. Rev. Jul., 2001, 101(7), 1869–1879. DOI: 10.1021/cr000108x.
   PubMed Web of Science ®Google Scholar
• Khademhosseini, A.; Langer, R. Microengineered hydrogels for tissue engineering. Biomaterials Dec., 2007, 28(34), 5087–5092. DOI: 10.1016/j.biomaterials.2007.07.021.
   PubMed Web of Science ®Google Scholar
• Nguyen, K. T.; West, J. L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials. 2002, 23(22), 4307–4314. DOI: 10.1016/S0142-9612(02)00175-8.
   PubMed Web of Science ®Google Scholar
• Hoffman, A. S. Hydrogels for biomedical applications. Advanced Drug. Delivery Reviews Dec., 2012, 64(Suppl), 18–23. DOI: 10.1016/j.addr.2012.09.010.
   Google Scholar
• Peppas, N. A., Bures, P., Leobandung, W., and Ichikawa, H. Hydrogels in pharmaceutical formulations.” [Online]. Available: www.elsevier.com/locate/ejphabio.
   Google Scholar
• Parhi, R. Cross-linked hydrogel for pharmaceutical applications: A review. Adv. Pharm. Bull. 2017, 7(4), 515–530. DOI: 10.15171/apb.2017.064.
   PubMed Web of Science ®Google Scholar
• Van Tomme, S. R.; Storm, G.; Hennink, W. E. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int. J. Pharmaceutics May 1, 2008. 355(1–2), 1–18. DOI: 10.1016/j.ijpharm.2008.01.057.
   PubMed Web of Science ®Google Scholar
• Drury, J. L.; Mooney, D. J. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003, 24(24), 4337–4351. DOI: 10.1016/S0142-9612(03)00340-5.
   PubMed Web of Science ®Google Scholar
• Caló, E.; Khutoryanskiy, V. V. Biomedical applications of hydrogels: A review of patents and commercial products. Eur. Polym. J. 2015, 65, 252–267. DOI: 10.1016/j.eurpolymj.2014.11.024.
   Web of Science ®Google Scholar
• Kline, S. Kinetics of drug release from hydrogel matrices* Ping I. Lee. J. Controlled Release 1985. 5(6), 277–288.
   Google Scholar
• Brandl, F.; Kastner, F.; Gschwind, R. M.; Blunk, T.; Teßmar, J.; Göpferich, A. Hydrogel-based drug delivery systems: Comparison of drug diffusivity and release kinetics. J. Controlled. Release Mar., 2010, 142(2), 221–228. DOI: 10.1016/j.jconrel.2009.10.030.
   PubMed Web of Science ®Google Scholar
• Jeznach, O.; Kołbuk, D.; Sajkiewicz, P. Injectable hydrogels and nanocomposite hydrogels for cartilage regeneration. J. Biomedical Materials Research - Part A 106(10), 2762–2776. DOI: 10.1002/jbm.a.36449. (Oct. 1, 2018).
   PubMed Web of Science ®Google Scholar
• Liu, M.; Zeng, X.; Ma, C.; Yi, H.; Ali, Z.; Mou, X.; Li, S.; Deng, Y.; He, N. Injectable hydrogels for cartilage and bone tissue engineering. Bone. Res. May 30, 2017. 5(1). DOI: 10.1038/boneres.2017.14.
   Google Scholar
• Wu, J.; Chen, Q.; Deng, C.; Xu, B.; Zhang, Z.; Yang, Y.; Lu, T. Exquisite design of injectable hydrogels in cartilage repair. Theranostics 2020, 10(21), 9843–9864. DOI: 10.7150/thno.46450.
   PubMed Web of Science ®Google Scholar
• Celik, C.; Mogal, V. T.; Hui, J. H. P.; Loh, X. J.; Toh, W. S. Injectable Hydrogels for Cartilage Regeneration; 2018; pp. 315–337. DOI: 10.1007/978-981-10-6077-9_12.
   Google Scholar
• Chen, G.; Kawazoe, N.; Ito, Y. “Photo-crosslinkable hydrogels for tissue engineering applications,” in Photochemistry for Biomedical Applications: From Device Fabrication to Diagnosis and Therapy; Springer Singapore, 2018; pp. 277–300. DOI: 10.1007/978-981-13-0152-0_10.
   Google Scholar
• Tan, H.; Chu, C. R.; Payne, K. A.; Marra, K. G. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials May., 2009, 30(13), 2499–2506. DOI: 10.1016/j.biomaterials.2008.12.080.
   PubMed Web of Science ®Google Scholar
• Sala, R. L.; Kwon, M. Y.; Kim, M.; Gullbrand, S. E.; Henning, E. A.; Mauck, R. L.; Camargo, E. R.; Burdick, J. A. *Thermosensitive Poly(N-vinylcaprolactam) Injectable Hydrogels for Cartilage Tissue Engineering. Tissue. Eng. Part A Sep., 2017, 23(17–18), 935–945. DOI: 10.1089/ten.tea.2016.0464.
   PubMed Web of Science ®Google Scholar
• Shu, X. Z.; Liu, Y.; Palumbo, F. S.; Luo, Y.; Prestwich, G. D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials. 2004, 25(7–8), 1339–1348. DOI: 10.1016/j.biomaterials.2003.08.014.
   PubMed Web of Science ®Google Scholar
• Jeon, O.; Samorezov, J. E.; Alsberg, E. Single and Dual Crosslinked Oxidized Methacrylated Alginate/PEG Hydrogels for Bioadhesive Applications. Acta. Biomater. 2014, 10(1), 47–55. DOI: 10.1016/j.actbio.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Suo, H.; Zhang, D.; Yin, J.; Qian, J.; Wu, Z. L.; Fu, J. Interpenetrating polymer network hydrogels composed of chitosan and photocrosslinkable gelatin with enhanced mechanical properties for tissue engineering. Mater. Sci. Eng. C Nov., 2018, 92, 612–620. DOI: 10.1016/j.msec.2018.07.016.
   PubMed Web of Science ®Google Scholar
• Schuurmans, C. C. L.; Mihajlovic, M.; Hiemstra, C.; Ito, K.; Hennink, W. E.; Vermonden, T. Hyaluronic acid and chondroitin sulfate (meth)acrylate-based hydrogels for tissue engineering: Synthesis, characteristics and pre-clinical evaluation. Biomaterials Jan 1, 2021. 268, 120602. DOI: 10.1016/j.biomaterials.2020.120602.
   PubMed Web of Science ®Google Scholar
• Chen, Z.; Zhao, M.; Liu, K.; Wan, Y.; Li, X.; Feng, G. Novel Chitosan Hydrogel Formed by Ethylene Glycol Chitosan, 1,6-Diisocyanatohexan and Polyethylene Glycol-400 for Tissue Engineering Scaffold: In vitro and in vivo Evaluation. J. Mater. Sci. Mater. Med. 2014, 25(8), 1903–1913. DOI: 10.1007/s10856-014-5223-3.
   PubMed Web of Science ®Google Scholar
• Wang, T.; Nie, J.; Yang, D. Dextran and gelatin based photocrosslinkable tissue adhesive. Carbohydr. Polym. Nov., 2012, 90(4), 1428–1436. DOI: 10.1016/j.carbpol.2012.07.011.
   PubMed Web of Science ®Google Scholar
• Rizzi, S. C.; Hubbell, J. A. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: Development and physicochemical characteristics. Biomacromolecules May., 2005, 6(3), 1226–1238. DOI: 10.1021/bm049614c.
   PubMed Web of Science ®Google Scholar
• Xiang, J.; Shen, L.; Hong, Y. Status and future scope of hydrogels in wound healing: Synthesis, materials and evaluation. Eur. Polym. J. May 5, 2020. 130. DOI: 10.1016/j.eurpolymj.2020.109609.
   PubMed Web of Science ®Google Scholar
• Basu, S.; Pacelli, S.; Paul, A. Self-healing DNA-based injectable hydrogels with reversible covalent linkages for controlled drug delivery. Acta. Biomater Mar., 2020, 105, 159–169. DOI: 10.1016/j.actbio.2020.01.021.
   PubMed Web of Science ®Google Scholar
• Li, H.; Cheng, F.; Wei, X.; Yi, X.; Tang, S.; Wang, Z.; Zhang, Y. S.; He, J.; Huang, Y. Injectable, self-healing, antibacterial, and hemostatic N,O-carboxymethyl chitosan/oxidized chondroitin sulfate composite hydrogel for wound dressing. Mater. Sci. Eng. C Jan., 2021, 118, 111324. DOI: 10.1016/j.msec.2020.111324.
   PubMed Web of Science ®Google Scholar
• Ren, Y.; Zhao, X.; Liang, X.; Ma, P. X.; Guo, B. Injectable hydrogel based on quaternized chitosan, gelatin and dopamine as localized drug delivery system to treat Parkinson’s disease. Int. J. Biol. Macromol. Dec., 2017, 105, 1079–1087. DOI: 10.1016/j.ijbiomac.2017.07.130.
   PubMed Web of Science ®Google Scholar
• Yuan, Y.; Shen, S.; Fan, D. A physicochemical double cross-linked multifunctional hydrogel for dynamic burn wound healing: shape adaptability, injectable self-healing property and enhanced adhesion. Biomaterials Sep., 2021, 276. DOI: 10.1016/j.biomaterials.2021.120838.
   Web of Science ®Google Scholar
• Khamrai, M.; Banerjee, S. L.; Paul, S.; Samanta, S.; Kundu, P. P. Curcumin entrapped gelatin/ionically modified bacterial cellulose based self-healable hydrogel film: An eco-friendly sustainable synthesis method of wound healing patch. Int. J. Biol. Macromol. Feb., 2019, 122, 940–953. DOI: 10.1016/j.ijbiomac.2018.10.196.
   PubMed Web of Science ®Google Scholar
• Yang, J.; Chen, Y.; Zhao, L.; Feng, Z.; Peng, K.; Wei, A.; Wang, Y.; Tong, Z.; Cheng, B. Preparation of a chitosan/carboxymethyl chitosan/AgNPs polyelectrolyte composite physical hydrogel with self-healing ability, antibacterial properties, and good biosafety simultaneously, and its application as a wound dressing. Compos. B Eng. Sep., 2020, 197, 108139. DOI: 10.1016/j.compositesb.2020.108139.
   Web of Science ®Google Scholar
• Hu, H.; Xu, F. J. Rational design and latest advances of polysaccharide-based hydrogels for wound healing. Biomater. Sci. Apr 21, 2020. 8(8), 2084–2101. DOI: 10.1039/d0bm00055h.
   PubMed Web of Science ®Google Scholar
• Tronci, G.; Grant, C. A.; Thomson, N. H.; Russell, S. J.; Wood, D. J. Multi-scale mechanical characterization of highly swollen photo-activated collagen hydrogels. J. R. Soc. Interface 2015, 12(102). DOI: 10.1098/rsif.2014.1079.
   PubMed Web of Science ®Google Scholar
• Qu, J.; Zhao, X.; Liang, Y.; Zhang, T.; Ma, P. X.; Guo, B. Antibacterial adhesive injectable hydrogels with rapid self-healing, extensibility and compressibility as wound dressing for joints skin wound healing. Biomaterials Nov., 2018, 183, 185–199. DOI: 10.1016/j.biomaterials.2018.08.044.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Abandansari, H.; Pakian, S.; Nabid, M. R.; Ebrahimi, M.; Rezalotfi, A. Local co-delivery of 5-fluorouracil and curcumin using Schiff’s base cross-linked injectable hydrogels for colorectal cancer combination therapy. European. Polymer J. Aug., 2021, 157, 110646. DOI: 10.1016/j.eurpolymj.2021.110646.
   Web of Science ®Google Scholar
• Zhang, Q.; Qiao, Y.; Zhu, J.; Li, Y.; Li, C.; Lin, J.; Li, X.; Han, H.; Mao, J.; Wang, F., et al. Electroactive and antibacterial surgical sutures based on chitosan-gelatin/tannic acid/polypyrrole composite coating. Compos. B Eng. Oct., 2021, 223, 109140. DOI: 10.1016/j.compositesb.2021.109140.
   Web of Science ®Google Scholar
• Bajpai, S. K.; Sonkusley, J. Hydrogels for oral drug delivery of peptides: Synthesis and characterization. J. Appl. Polym. Sci Feb., 2002, 83(8), 1717–1729. DOI: 10.1002/app.10097.
   Web of Science ®Google Scholar
• Gupta, H.; Velpandian, T.; Jain, S. Ion-and pH-activated novel in-situ gel system for sustained ocular drug delivery. J. Drug. Target Aug., 2010, 18(7), 499–505. DOI: 10.3109/10611860903508788.
   PubMed Web of Science ®Google Scholar
• Watts, P.; Smith, A. PecSys: In situ gelling system for optimised nasal drug delivery. Expert Opin. Drug Delivery May., 2009, 6(5), 543–552. DOI: 10.1517/17425240902939135.
   PubMed Web of Science ®Google Scholar
• Galankar, V. P.; Patil, S. B.; Upasani, C. D.; Pingale, P. L.; Amrutkar, S. V. Journal of medical pharmaceutical and allied sciences. 1906, 1. DOI: 10.22270/jmpas.2021.IC1I5.1906.
   Google Scholar
• Morishita, M.; Goto, T.; Nakamura, K.; Lowman, A. M.; Takayama, K.; Peppas, N. A. Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats. J. Controlled Release Feb., 2006, 110(3), 587–594. DOI: 10.1016/j.jconrel.2005.10.029.
   PubMed Web of Science ®Google Scholar
• Almeida, H., Amaral, M. H., Lobão, P., and Lobo, J. M. S. In situ gelling systems: A strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug. Discovery Today 2014, 19(4), pp. 400–412. DOI: 10.1016/j.drudis.2013.10.001.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, K.; Ganguly, K.; Nadagouda, M. N.; Aminabhavi, T. M. Polymeric hydrogels for oral insulin delivery. J. Controlled Release Jan 28, 2013. 165(2), 129–138. DOI: 10.1016/j.jconrel.2012.11.005.
   PubMed Web of Science ®Google Scholar
• Morishita, M.; Goto, T.; Takayama, K.; Peppas, N. A. Oral insulin delivery systems based on complexation polymer hydrogels. J. Drug. Delivery Sci. Technol. 2006, 16(1), 19–24. DOI: 10.1016/s1773-2247(06)50003-6.
   Web of Science ®Google Scholar
• Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., and Rudzinski, W. E. “Biodegradable polymeric nanoparticles as drug delivery devices,” 2001. [Online]. Available: www.elsevier.com/locate/jconrel.
   Google Scholar
• Ghasemiyeh, P.; Mohammadi-Samani, S. Hydrogels as Drug Delivery Systems; Pros and Cons. Trends Pharm. Sci. 2019, 5(1), 7–24.
   Google Scholar
• Rupenthal, I. D.; Alany, R. G.; Green, C. R. Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface. Mol. Pharm. Dec., 2011, 8(6), 2282–2290. DOI: 10.1021/mp200140e.
   PubMedGoogle Scholar
• Gupta, H.; Jain, S.; Mathur, R.; Mishra, P.; Mishra, A. K.; Velpandian, T. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug. Deliv. Nov., 2007, 14(8), 507–515. DOI: 10.1080/10717540701606426.
   PubMed Web of Science ®Google Scholar
• Sosnik, A.; Seremeta, K. P. Polymeric hydrogels as technology platform for drug delivery applications. Gels Sep 1, 2017. 3(3). DOI: 10.3390/gels3030025.
   PubMedGoogle Scholar
• Liow, S. S.; Dou, Q.; Kai, D.; Karim, A. A.; Zhang, K.; Xu, F.; Loh, X. J. Thermogels: In Situ Gelling Biomaterial. ACS Biomater. Sci. Eng. Mar 14, 2016. 2(3), 295–316. DOI: 10.1021/acsbiomaterials.5b00515.
   PubMed Web of Science ®Google Scholar
• Coviello, T.; Matricardi, P.; Marianecci, C.; Alhaique, F. Polysaccharide hydrogels for modified release formulations. J. Controlled Release May 14, 2007. 119(1), 5–24. DOI: 10.1016/j.jconrel.2007.01.004.
   PubMed Web of Science ®Google Scholar
• Ito, T.; Fraser, I. P.; Yeo, Y.; Highley, C. B.; Bellas, E.; Kohane, D. S. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials Apr., 2007, 28(10), 1778–1786. DOI: 10.1016/j.biomaterials.2006.12.012.
   PubMed Web of Science ®Google Scholar
• Merceron, C.; Portron, S.; Masson, M.; Lesoeur, J.; Fellah, B. H.; Gauthier, O.; Geffroy, O.; Weiss, P.; Guicheux, J.; Vinatier, C., et al. The effect of two- and three-dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell. Transplant. 2011, 20(10), 1575–1588.
   PubMed Web of Science ®Google Scholar
• Khunmanee, S.; Jeong, Y.; Park, H. Crosslinking method of hyaluronic-based hydrogel for biomedical applications. J. Tissue Eng. Jan., 2017, 8. DOI: 10.1177/2041731417726464.
   PubMed Web of Science ®Google Scholar
• Jin, R.; Moreira Teixeira, L. S.; Dijkstra, P. J.; van Blitterswijk, C. A.; Karperien, M.; Feijen, J. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials Apr., 2010, 31(11), 3103–3113. DOI: 10.1016/j.biomaterials.2010.01.013.
   PubMed Web of Science ®Google Scholar
• Ma, X.; Xu, T.; Chen, W.; Qin, H.; Chi, B.; Ye, Z. Injectable hydrogels based on the hyaluronic acid and poly (γ-glutamic acid) for controlled protein delivery. Carbohydr. Polym. Jan., 2018, 179, 100–109. DOI: 10.1016/j.carbpol.2017.09.071.
   PubMed Web of Science ®Google Scholar
• Hozumi, T.; Kageyama, T.; Ohta, S.; Fukuda, J.; Ito, T. Injectable Hydrogel with Slow Degradability Composed of Gelatin and Hyaluronic Acid Cross-Linked by Schiff’s Base Formation. Biomacromolecules. Feb., 2018, 19(2), 288–297. DOI: 10.1021/acs.biomac.7b01133.
   PubMed Web of Science ®Google Scholar
• Nakai, T.; Hirakura, T.; Sakurai, Y.; Shimoboji, T.; Ishigai, M.; Akiyoshi, K. Injectable Hydrogel for Sustained Protein Release by Salt-Induced Association of Hyaluronic Acid Nanogel. Macromol. Biosci. Apr., 2012, 12(4), 475–483. DOI: 10.1002/mabi.201100352.
   PubMed Web of Science ®Google Scholar
• Lu, Z.; Liu, S.; Le, Y.; Qin, Z.; He, M.; Xu, F.; Zhu, Y.; Zhao, J.; Mao, C.; Zheng, L. An injectable collagen-genipin-carbon dot hydrogel combined with photodynamic therapy to enhance chondrogenesis. Biomaterials Oct., 2019, 218, 119190. DOI: 10.1016/j.biomaterials.2019.05.001.
   PubMed Web of Science ®Google Scholar
• Wang, H.; Zhu, D.; Paul, A.; Cai, L.; Enejder, A.; Yang, F.; Heilshorn, S. C. Covalently Adaptable Elastin-Like Protein–Hyaluronic Acid (ELP–HA) Hybrid Hydrogels with Secondary Thermoresponsive Crosslinking for Injectable Stem Cell Delivery. Adv. Funct. Mater. Jul., 2017, 27(28). DOI: 10.1002/adfm.201605609.
   Web of Science ®Google Scholar
• Matricardi, P.; Di Meo, C.; Coviello, T.; Hennink, W. E.; Alhaique, F. Interpenetrating polymer networks polysaccharide hydrogels for drug delivery and tissue engineering. Advanced. Drug. Delivery Reviews Aug 1, 2013. 65(9), 1172–1187. DOI: 10.1016/j.addr.2013.04.002.
   PubMed Web of Science ®Google Scholar
• Tous, E.; Tous, E.; Ifkovits, J. L.; Koomalsingh, K. J.; Shuto, T.; Soeda, T.; Kondo, N.; Budrick, J. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 2011, 12(11), 4127–4135. DOI: 10.1021/bm201198x.
   PubMed Web of Science ®Google Scholar
• Arora, A.; Mahajan, A.; Katti, D. S. TGF-β1 presenting enzymatically cross-linked injectable hydrogels for improved chondrogenesis. Colloids Surf. B Biointerfaces Nov., 2017, 159, 838–848. DOI: 10.1016/j.colsurfb.2017.08.035.
   PubMed Web of Science ®Google Scholar